Liquefaction device, method and system
The medication ultrasonication unit addresses the challenge of precise liquefaction and compliance by using data-driven ultrasonic energy parameters, optimizing medication preparation and administration, thereby improving patient outcomes.
Patent Information
- Application Number
- PCT/AU2024/050494
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-19
- Filing Date
- 2024-05-17
- Publication Date
- 2024-11-28
AI Technical Summary
Existing methods for liquefying medication doses lack precision in ultrasonication time and are cumbersome for ensuring correct dosage administration, particularly for individuals with dysphagia or those struggling with tablet size, shape, or taste, leading to potential errors in medication compliance.
A medication ultrasonication unit equipped with a processor, memory, and ultrasound transducer, which receives data on medication characteristics via wireless transceivers or input devices, providing customized ultrasonic energy parameters for optimal liquefaction, including sonication time, frequency, and duration, and integrates with AI tools for predictive liquefaction times, ensuring accurate and efficient medication preparation.
The system optimizes medication liquefaction, enhances patient compliance by ensuring correct dosing, and streamlines the administration process, reducing errors and improving health outcomes by providing personalized and efficient medication preparation.
Smart Images

Figure AU2024050494_28112024_PF_FP_ABST
Abstract
Description
LIQUEFACTION DEVICE, METHOD AND SYSTEMFIELD OF INVENTION
[0001] The present invention relates to the field of devices for preparing doses of prescription or non-prescription medication for human or animal consumption.
[0002] In one form, the invention relates to a system for liquefying medication doses.
[0003] In one particular aspect the present invention is suitable for use in controlling the liquefying and administration of medication doses.
[0004] It will be convenient to hereinafter describe the invention in relation to medication doses comprising prescription medicines, however it should be appreciated that the present invention is not limited to that use only and can be used for a wide range of non-prescription, over-the-counter medications for medical and veterinary applications.BACKGROUND ART
[0005] It is to be appreciated that any discussion of documents, devices, acts or knowledge in this specification is included to explain the context of the present invention. Further, the discussion throughout this specification comes about due to the realisation of the inventor and / or the identification of certain related art problems by the inventor. Moreover, any discussion of material such as documents, devices, acts or knowledge in this specification is included to explain the context of the invention in terms of the inventor's knowledge and experience and, accordingly, any such discussion should not be taken as an admission that any of the material forms part of the prior art base or the common general knowledge in the relevant art in Australia, or elsewhere, on or before the priority date of the disclosure and claims herein.
[0006] Ultrasonication is the act of applying sound energy (of > 20 kHz) to agitate particles and cause various physical effects. Ultrasonication can be used to speed dissolution of solid particles into a liquid by breaking intermolecular interactions.
[0007] The use of an ultrasonication device to liquefy medications for people with dysphagia has previously been described in Australian application patent no.s 2013204792 and 2016224136 and international patent application PCT / AU2013 / 001147. A user adds liquid and a medication dose to a receptacle, inserts the receptacle into the device where an ultrasound transducer generates ultrasonic energy that it causes disintegration of the solid into the liquid in the vessel. A flavouring material may be added to improve the palatability.
[0008] Where used herein, the term 'liquefaction', 'liquefy' and the like includes ultrasonication of a solid such that the solid dissolves, mixes or blends into a liquid and includes formation of solutions, suspensions and dispersions.
[0009] Where used herein, the term 'medication' is interpreted broadly to refer not only to pharmaceutical or prescription medicines that are used to treat and cure illness or pain, but also to preparations that improve health, such as vitamins, which are desirable for normal growth and health and are useful in the diet because they cannot be synthesised by the body. A 'dose' is a quantity of the medication that is taken or recommended to be taken at a particular time, time period or according to a dosage regimen.
[0010] Liquefaction of doses of medication is not only apt for people with dysphagia, but also for others who struggle to swallow dose forms due to their size, shape or taste. For example, calcium tablets are often very large, and many consumers crush or grind the tablet into particles.
[0011] Liquefaction of a dose of medication may also make it easier to administer veterinary medication doses. Cats in particular are known to resist swallowing tablets or appear to swallow a tablet then spit it out later.
[0012] One of the disadvantages associated with the prior art is that a user does not know exactly how long to apply the ultrasonication to the medication dose. The resilience or resistance of dose forms to ultrasonication depends on a variety of factors including size, shape, binder strength, composition and the presence of any coatings. This resistance varies from medication to medication. For a given medication, the resistance can also vary from batch to batch, or manufacturer to manufacturer.
[0013] Another disadvantage of the prior art is the difficulty of ensuring that patients prepare and take the correct medication dose at the correct time. This disadvantage is not limited to ultrasonic devices but extends more generally to all methods of dispensing of medication doses for consumption. In hospitals and aged care facilities, staff must administer a wide range of medications according to myriad regimes. Matching the patient to their medication dose, at the correct time, and applying the appropriate amount of ultrasonic energy to a given dose is difficult, time consuming, and errors can have serious adverse outcomes for a patient.
[0014] Individuals may also struggle to apply ultrasonication to their own medication dosage for the appropriate amount of time.
[0015] Accordingly, there is a need for users to have certainty that their liquefaction of a medication dose is optimal. There is also a need for improving compliance with dosage regimens and that the correct medication is consumed.SUMMARY OF INVENTION
[0016] An object of the present invention is to provide a system for optimising liquefaction of medication dosages to improved swallowability of medication doses.
[0017] Another object of the present invention is to provide a system for providing liquefaction of a medication dose with improved compliance with a dosage regime.
[0018] Another object of the present invention is to provide a system for liquefaction of medication doses, customised to the characteristics of individual medications.
[0019] Yet another object of the present invention is to provide an integrated system for providing liquefied medication doses and improved treatment and health outcomes.
[0020] A further object of the present invention is to alleviate at least one disadvantage associated with the related art.
[0021] It is an object of the embodiments described herein to overcome or alleviate at least one of the above noted drawbacks of related art systems or to at least provide a useful alternative to related art systems.
[0022] In a first aspect of embodiments described herein there is provided a medication ultrasonication unit, comprising: a processor; a memory coupled with and readable by the processor to cause the processor to perform a plurality of functions controlling the sonication of medication in the medication ultrasonication unit; at least one data receiver in communication with the processor; and an ultrasound transducer generating ultrasonic energy under direction of the processor; wherein the medication ultrasonication unit is adapted to: hold a receptacle loaded with a liquid and a medication dose, receive data relating to the medication dose via the data receiver and transmit the data to the memory, ultrasonicate the dose under control of the plurality of functions, wherein the plurality of functions includes one or more functions for ultrasonicating the medication dose based on the information associated with the data.
[0023] In one embodiment of the present invention, the ultrasonication unit memory is cloud enabled. Users can choose to interact to gain access to suggested machine instructions. This includes some of all aspects of ultrasonic unit memory and storage being associated with cloud based servers.
[0024] The information associated with the data may include machine instructions developed from an artificial intelligence (Al) tool that uses machine learning based on data gained through interaction with users to determine conditions for liquefaction of medications from a database provided by third parties such as pharmacists or drug companies. The Al tool may for example, have access to specifications for each medication and other data and with training may become predictive of machine times to liquify the medications.Data associated with the medication dose
[0025] The data receiver may comprise one or more wireless transceivers. Alternatively, or in addition, the data receiver may be associated with an input / output device chosen from a scanner, a wireless transceiver, a keyboard, a touch screen and / or tactile buttons.
[0026] The data transmitted from the data receiver to the memory is typically in machine readable code that is issued by a manufacturer, distributor or dispensing pharmacist. The data typically identifies the medication dose (ie identity of the active, dose level, dose timing / regimen details). Importantly, the data typically includes some or all of the information for operation of the ultrasonication unit, customised or corresponding to the identification of the medication dose.
[0027] The information for operation of the ultrasonic unit typically includes a sonication time, being the time take to liquify the medication dosage. The information may also include control parameters for controlling the frequency of the ultrasonication and the amount of time period for which the frequency is applied. For example, the information may include parameters for operating the ultrasonic unit at predetermined frequencies for predetermined periods of time to optimise liquefaction.
[0028] The receptacle may be loaded with the medication dose and liquid by the user. Typically, the medication dose is released from packaging that includes a barcode, such as a 2-D barcode (typically referred to as a QR code) Universal product codes (UPC), European article numbers (EAN), image barcodes, digimarc barcodes, RFID and NFC bearing data that identifies the medication dose and may also contain information necessary for the unit to ultrasonicate the dose. In another embodiment, the dose and / or liquid may be supplied to the user in a pre-loaded disposable receptacle bearing a barcode.
[0029] In yet another embodiment, the receptacle may be loaded with the medication dose and liquid by the user, who has a barcode downloaded on their mobile phone or other mobile electronic device. Alternatively, or in addition, a machine readable code may be transmitted to the wireless transceivers directly from a pharmacy.
[0030] In another aspect of embodiments described herein there is provided a method of liquefying a solid medication dose using the ultrasonic unit of the present invention, the method comprising the steps of: loading the receptacle with a liquid and a dose of medication, receiving data relating to the medication dose from at least one data receiver, transmitting the data to the memory, and ultrasonicating the dose based on the information associated with the data.
[0031] In yet a further aspect of embodiments described herein there is provided a method of producing a liquefied medication dose from a solid medication dose using the ultrasonic unit of the present invention, the method comprising the steps of: locating within the unit, a removable receptacle loaded with a liquid and a dose of medication, receiving data from two or more input / output devices, transmitting the data to the memory, ultrasonicating the dose based on information associated with the data, and removing the receptacle from the unit.
[0032] In yet a further aspect of embodiments described herein there is provided a medication ultrasonic unit, according to the present invention, the processor being configured to perform the steps of: receiving data from the data receiver; transmitting the data to the memory, directing the ultrasound transducer to generate ultrasonic energy based on information associated with the data, to liquefy the medication dose in the receptacle.Identification of compatibility problems or interaction problems
[0033] Preferably the plurality of functions of the processor includes one or more functions for identifying a compatibility problem or interaction problem based on the data. Optimally, this would result in a warning being issued or prevention of sonication of the dose. The warning may be issued, for example, on a lamp or display of the sonication unit, or the user's mobile phone or other mobile device. The warning may be audible or visible.
[0034] In one embodiment, the warning issues in response to the processor identifying incompatibility between data cross-referenced from two or more sources of data, such as user identification data associated with a password, passcode, facial or eye scan, or fingerprint.
[0035] For example, if the ultrasonication unit wirelessly received data relating to a user's prescribed dosage, and the user manually scanned a QR code relating to medication dosage on the medication dosage or its packaging that did not correlate with wireless information, a warning may issue, or the unit may not initiate sonication. Alternatively, the user may need to carry out a fingerprint scan using a scanner on the ultrasonication unit to ensure that their identity correlates with the user recorded against the information data of the QR code.
[0036] Other aspects and preferred forms are disclosed in the specification and / or defined in the appended claims, forming a part of the description of the invention.
[0037] In essence, embodiments of the present invention stem from the realisation that a dose can be associated with data sets that dictate best procedures for its transition into a more swallowable form. Furthermore, the data can be used to police the dosing regimen for a user.
[0038] Advantages provided by the present invention comprise the following: liquefaction of medication doses can be optimally carried out on-demand by a user, liquefaction of medication doses is consistently optimised, leading to improved patient compliance, liquefaction of medication doses is streamlined with improved recording and reporting.
[0039] Further scope of applicability of embodiments of the present invention will become apparent from the detailed description given hereinafter. However, it should be understood that the detailed description and specific examples, while indicating preferred embodiments of the invention, are given by way of illustration only, since various changes and modifications within the spirit and scope of the disclosure herein will become apparent to those skilled in the art from this detailed description.BRIEF DESCRIPTION OF THE DRAWINGS
[0040] Further disclosure, objects, advantages and aspects of preferred and other embodiments of the present application may be better understood by those skilled in the relevant art by reference to the following description of embodiments taken in conjunction with the accompanying drawings, which are given by way of illustration only, and thus are not limitative of the disclosure herein, and in which:• FIG 1 illustrates a high level map of interactions between various components according to the system of the present invention;• FIG 2 illustrates an ultrasonication unit of the type used for the present invention;• FIG 3 illustrates the relationship between data input and machine learning output; and• FIG 4 illustrates the relationship between the machine learning output, users and the sonication machine.
[0041] List of PartsDETAILED DESCRIPTION
[0042] It is to be understood that the specific devices and processes illustrated in the attached drawings, and described in the following specification are simply exemplary embodiments of the inventive concepts defined in the appended claims. Hence, specific dimensions and other physical characteristics relating to the embodiments disclosed herein are not to be considered as limiting, unless the claims expressly state otherwise. Additionally, unless otherwise specified, it is to be understood that discussion of a particular feature of component extending in or along a given direction or the like does not mean that the feature or component follows a straight line or axis in such a direction or that it only extends in such direction or on such a plane without other directional components or deviations, unless otherwise specified.Ultrasonication Unit
[0043] The embodiment of the system of the present invention as depicted in FIG 1, includes a medication ultrasonication unit (100), comprising an ultrasound transducer generating ultrasonic energy. The ultrasonic energy is directed to a receptacle (200) that can be loaded with a liquid and a dose of medication to liquefy the dose. The receptacle (200) may be reusable or may be disposable. In the latter case the receptacle (200) could be supplied by a manufacturer or dispensing pharmacist, pre-loaded with liquid and dose of medication and enclosed by a removable closure. The receptacle may also include a flavourant to counteract any unpleasant taste or mouthfeel of the liquefied dose.
[0044] The ultrasonication unit (100) may be powered by any convenient means including mains power or batteries. It may also be mobile or mounted in a convenient location, such as a wall or bench.
[0045] The ultrasonication unit (100) further includes a processing unit for controlling generation of ultrasonic energy by the ultrasound transducer. A memory coupled with and readable by the processor causes the processor to perform a plurality of functions that control the sonication of the dose of medication in ultrasonication unit (100).
[0046] The ultrasonic unit (100) also includes a data receiver, such as one or more wireless transceivers. Alternatively, or in addition, the data receiver may be associated with an input / output devices, such as a scanner, a wireless transceiver, a keyboard, a touch screen and / or tactile buttons.
[0047] Optimally a user (400) can use the input / output device to wirelessly communicate (500) with a mobile device (300). The wireless connectivity may be provided by any convenient means such as a cellular mobile network, wireless LAN, Bluetooth, ZigBee, ultra- wideband networks, wi-fi or satellite networks. In a particularly preferred embodiment, the user (400) communicates wirelessly using an app on a mobile phone.Software
[0048] Typically, the system includes software comprising instructions, data or programs to perform a number of tasks including: instructing operation of the ultrasonication unit (100) including ultrasonication run-time period for a given dose; tracking a dose regimen, including times and amounts of dose; re-ordering inventory such as doses, prescriptions for medications, receptacles, flavourants; collecting usage history; storing contact details such as for a pharmacy, doctor, carer, emergency services and others; receiving and sending data, to and from the abovementioned contacts and the ultrasonication unit (100).
[0049] The software may include, for example, application software (apps) that can reside on a mobile device such as a mobile phone. For example, an iPad loaded with an appropriate app that has user identification to manage medication at the local machine level.Data
[0050] Preferably, the data transmitted is sourced from a unique identifier (650) such as a barcode, two dimensional barcode (such as quick response (QR) codes), universal productcodes (UPC), European article numbers (EAN), image barcodes, digimarc barcodes, RFID and NFC. The unique identifier (650) may be printed, for example, as a sticker or label (600) for a container storing the medication dosages. Alternatively, the unique identifier may remain in electronic format.
[0051] The data transmitted from the data receiver to the memory is typically in machine readable code that is issued by a manufacturer (800), distributor (900) or dispensing pharmacist (700). The data typically identifies the medication dose (ie identity of the active, dose level, dose timing / regimen details). Importantly, the data typically includes some or all of the information for operation of the ultrasonication unit, customised or corresponding to the identification of the medication dose.
[0052] The information for operation of the ultrasonic unit typically includes a sonication time, being the time take to liquify the medication dosage. The information may also include control parameters for controlling the frequency of the ultrasonication.
[0053] For example, a pharmacy (700) may fulfil a user's prescription, issued by a medical practitioner (750) and generate a unique identifier code, typically a QR code that is attached to the packaging of the medication dosage. Alternatively, the pharmacy (700) may dispense, or sell over-the-counter, a medication dosage that has had an identifier code previously attached by a distributor (900) or manufacturer (800).
[0054] Alternatively, the unique identifier code may be sent directly to a mobile device (300) belonging to the user (400) or the user's carer (450).
[0055] FIG 3 illustrates how the system of the present invention gathers data from its interaction with users, and the data is fed into machine learning (1004). An Al tool (1005) uses the machine learning based on the data to determine conditions for liquefaction of medications and with training may become predictive of machine times to liquify the medications.
[0056] The data is typically derived from 3 sources: user data (1001) including the confirmed sonification times for medication combinations, testing data (1002) including information from sources that have tested medication combinations to determine their optimal sonification parameters; and industry data (1003) including test information derived from third parties such as pharmacists or drug companies.
[0057] FIG 4 illustrates the relationship between the Al tool which optimally resides in a public or private cloud server (1006) and the carer portal (1007) accessed by a carer (1008), the point of care (POC) app (1010) accessed by the user (1009) and the sonication unit (1011). Broken lines indicate the software interactions while unbroken lines indicate human / human interactions.Ultrasonication Unit
[0058] The present invention is suitable for use with various types of sonication units. A typical sonication unit (100) as depicted in FIG 2 has a housing (102) including an opening (122) into which a receptacle (120) containing a medication dosage and liquid may be received. A closure member (116) closes the opening in the housing (102). Inside the housing (102) is a power supply (104) and processor (106). The processor (106) is coupled to an ultrasound transducer (108) and other components such as a cover member actuator (124), each of which may be controlled by an electronic signal. The processor is in communication with one or more data receivers which may interface with input / output devices such as a touch screen display (114).
[0059] The processor (106) comprises control electronics preferably embodied in firmware written to read only memory (ROM) or programmable ROM (PROM) of a microprocessor. The control electronics may alternatively be provided on a stand alone computer or other memory-processor device operably connected to the unit (100) and its components.
[0060] A cooling unit (128) may maintain an acceptable temperature within the receptacle. This may be useful if particularly high intensity ultrasonic energy is applied to minimise the liquefaction time, or where liquefaction times are long and cause the contents of the receptacle to approach the limit of acceptable heating. The cooling unit may be thermostatically controlled or may operate according to signals from the processor (106).
[0061] The ultrasound transducer (108) generates ultrasonic energy under the control of the processor (106) and is coupled to annular coupling element (112) via an amplifier (110). The amplifier (110) amplifies the ultrasound signal from the transducer (108) to an intensity sufficient to cause disintegration of a medication dosage in the receptacle within a timeframe. Preferably a force actuator (126) applies force to the receptacle (120) when loaded in the annular coupling element (112) to enhance coupling between the annular coupling element (112) and the receptacle wall. This maximises ultrasonic energy transference to the receptacle contents.
[0062] Typically, the ultrasound transducer resonant frequency is in the range of 20 to 45 kHz. The operating frequency may be controlled by the processor (106). In a preferred embodiment, the ultrasound transducer (108) operates in a swept frequency mode. In swept frequency mode the signal driving the ultrasound transducer (108) and hence the ultrasonic energy emitted from the transducer (108) fluctuates between the resonant frequency and a non-resonant frequency.
[0063] The cover member (116) may utilise a two-stage actuator (124) during closure. In one stage, cover member (116) pivots around a hinge (124a); in another stage, cover member (116) is lowered into opening (122) via a vertical actuator (124b). Vertical actuator (124b) may be provided by resilient, pneumatic, hydraulic, electronic or other means and may operate manually via mechanical means or automatically, under control of the processor (106) to open and close the cover member (116).
[0064] The apparatus may also be fitted with a speaker (130) operated under control of the processor (106) to provide an audible alert when the liquefaction process is complete, or to issue a warning.
[0065] The unit (100) typically includes a data receiver through which the processor (106) may receive information in a wired or wireless manner, such as via a local area network (LAN) or wide area network (WAN), telephone line, wireless network or the like. The wireless connectivity may be provided by any convenient means such as a cellular mobile network, wireless LAN, Bluetooth, ZigBee, ultra-wideband networks, wi-fi or satellite networks. In a particularly preferred embodiment, the user (400) communicates wirelessly using an app on a mobile phone.
[0066] Input / output devices (132) can be operated by the user as an interface with the data receiver(s) and the processor (106). Input / output devices may, for example be chosen from a scanner, a wireless transceiver, a keyboard, a touch screen and / or tactile buttons.
[0067] While this invention has been described in connection with specific embodiments thereof, it will be understood that it is capable of further modification(s). This application is intended to cover any variations uses or adaptations of the invention following in general, the principles of the invention and including such departures from the present disclosure as come within known or customary practice within the art to which the invention pertains and as may be applied to the essential features hereinbefore set forth.
[0068] As the present invention may be embodied in several forms without departing from the spirit of the essential characteristics of the invention, it should be understood that the above described embodiments are not to limit the present invention unless otherwise specified, but rather should be construed broadly within the spirit and scope of the invention as defined in the appended claims. The described embodiments are to be considered in all respects as illustrative only and not restrictive.
[0069] Various modifications and equivalent arrangements are intended to be included within the spirit and scope of the invention and appended claims. Therefore, the specific embodiments are to be understood to be illustrative of the many ways in which the principles of the present invention may be practiced. In the following claims, means-plus-functionclauses are intended to cover structures as performing the defined function and not only structural equivalents, but also equivalent structures.
[0070] It should be noted that where the terms "server", "secure server" or similar terms are used herein, a communication device is described that may be used in a communication system, unless the context otherwise requires, and should not be construed to limit the present invention to any particular communication device type. Thus, a communication device may include, without limitation, a bridge, router, bridge-router (router), switch, node, or other communication device, which may or may not be secure.
[0071] It should also be noted that where a flowchart is used herein to demonstrate various aspects of the invention, it should not be construed to limit the present invention to any particular logic flow or logic implementation. The described logic may be partitioned into different logic blocks (e.g., programs, modules, functions, or subroutines) without changing the overall results or otherwise departing from the true scope of the invention. Often, logic elements may be added, modified, omitted, performed in a different order, or implemented using different logic constructs (e.g., logic gates, looping primitives, conditional logic, and other logic constructs) without changing the overall results or otherwise departing from the true scope of the invention.
[0072] Various embodiments of the invention may be embodied in many different forms, including computer program logic for use with a processor (e.g., a microprocessor, microcontroller, digital signal processor, or general purpose computer and for that matter, any commercial processor may be used to implement the embodiments of the invention either as a single processor, serial or parallel set of processors in the system and, as such, examples of commercial processors include, but are not limited to Merced™, Pentium™, Pentium II™, Xeon™, Celeron™, Pentium Pro™, Efficeon™, Athlon™, AMD™ and the like), programmable logic for use with a programmable logic device (e.g., a Field Programmable Gate Array (FPGA) or other PLD), discrete components, integrated circuitry (e.g., an Application Specific Integrated Circuit (ASIC)), or any other means including any combination thereof. In an exemplary embodiment of the present invention, predominantly all of the communication between users and the server is implemented as a set of computer programinstructions that is converted into a computer executable form, stored as such in a computer readable medium, and executed by a microprocessor under the control of an operating system.
[0073] Computer program logic implementing all or part of the functionality where described herein may be embodied in various forms, including a source code form, a computer executable form, and various intermediate forms (e.g., forms generated by an assembler, compiler, linker, or locator). Source code may include a series of computer program instructions implemented in any of various programming languages (e.g., an object code, an assembly language, or a high-level language such as Fortran, C, C++, JAVA, or HTML. Moreover, there are hundreds of available computer languages that may be used to implement embodiments of the invention, among the more common being Ada; Algol; APL; awk; Basic; C; C++; Conol; Delphi; Eiffel; Euphoria; Forth; Fortran; HTML; Icon; Java; Javascript; Lisp; Logo; Mathematica; MatLab; Miranda; Modula-2; Oberon; Pascal; Perl; PL / I; Prolog; Python; Rexx; SAS; Scheme; sed; Simula; Smalltalk; Snobol; SQL; Visual Basic; Visual C++; Linux and XML) for use with various operating systems or operating environments. The source code may define and use various data structures and communication messages. The source code may be in a computer executable form (e.g., via an interpreter), or the source code may be converted (e.g., via a translator, assembler, or compiler) into a computer executable form.
[0074] The computer program may be fixed in any form (e.g., source code form, computer executable form, or an intermediate form) either permanently or transitorily in a tangible storage medium, such as a semiconductor memory device (e.g, a RAM, ROM, PROM, EEPROM, or Flash-Programmable RAM), a magnetic memory device (e.g., a diskette or fixed disk), an optical memory device (e.g., a CD-ROM or DVD-ROM), a PC card (e.g., PCMCIA card), or other memory device. The computer program may be fixed in any form in a signal that is transmittable to a computer using any of various communication technologies, including, but in no way limited to, analog technologies, digital technologies, optical technologies, wireless technologies (e.g., Bluetooth), networking technologies, and inter-networking technologies. The computer program may be distributed in any form as a removable storage medium with accompanying printed or electronic documentation (e.g., shrink wrapped software), preloaded with a computer system (e.g., on system ROM or fixed disk), or distributed from aserver or electronic bulletin board over the communication system (e.g., the Internet or World Wide Web).
[0075] Hardware logic (including programmable logic for use with a programmable logic device) implementing all or part of the functionality where described herein may be designed using traditional manual methods, or may be designed, captured, simulated, or documented electronically using various tools, such as Computer Aided Design (CAD), a hardware description language (e.g., VHDL or AHDL), or a PLD programming language (e.g., PALASM, ABEL, or CUPL). Hardware logic may also be incorporated into display screens for implementing embodiments of the invention and which may be segmented display screens, analogue display screens, digital display screens, CRTs, LED screens, Plasma screens, liquid crystal diode screen, and the like.
[0076] Programmable logic may be fixed either permanently or transitorily in a tangible storage medium, such as a semiconductor memory device (e.g., a RAM, ROM, PROM, EEPROM, or Flash-Programmable RAM), a magnetic memory device (e.g., a diskette or fixed disk), an optical memory device (e.g., a CD-ROM or DVD-ROM), or other memory device. The programmable logic may be fixed in a signal that is transmittable to a computer using any of various communication technologies, including, but in no way limited to, analog technologies, digital technologies, optical technologies, wireless technologies (e.g., Bluetooth), networking technologies, and internetworking technologies. The programmable logic may be distributed as a removable storage medium with accompanying printed or electronic documentation (e.g., shrink wrapped software), preloaded with a computer system (e.g., on system ROM or fixed disk), or distributed from a server or electronic bulletin board over the communication system (e.g., the Internet or World Wide Web).
[0077] When a Markush group or other grouping is used herein, all individual members of the group and all combinations and sub-combinations possible of the group members are intended to be individually included in the disclosure. Every combination of components described or exemplified herein can be used to practice the invention, unless otherwise stated.
[0078] Whenever a range is given in the specification, for example, a temperature range, a time range, or a composition or concentration range, all intermediate ranges and subranges, as well as all individual values included in the ranges given are intended to be included in the disclosure. It will be understood that any subranges or individual values in a range or subrange that are included in the description herein can be excluded from the claims herein.
[0079] As used herein, "comprising" is synonymous with "including," "containing," or "characterised by," and is inclusive or open-ended and does not exclude additional, unrecited elements or method steps. As used herein, "consisting of' excludes any element, step, or ingredient not specified in the claim element. As used herein, "consisting essentially of' does not exclude materials or steps that do not materially affect the basic and novel characteristics of the claim. The broad term "comprising" is intended to encompass the narrower "consisting essentially of' and the even narrower "consisting of." Thus, in any recitation herein of a phrase "comprising one or more claim element" (e.g., "comprising A), the phrase is intended to encompass the narrower, for example, "consisting essentially of A" and "consisting of A". Thus, the broader word "comprising" is intended to provide specific support in each use herein for either "consisting essentially of' or "consisting of". The invention illustratively described herein suitably may be practiced in the absence of any element or elements, limitation or limitations which is not specifically disclosed herein.
[0080] One of ordinary skill in the art will appreciate that materials and methods, other than those specifically exemplified can be employed in the practice of the invention without resort to undue experimentation. All art-known functional equivalents, of any such materials and methods are intended to be included in this invention. The terms and expressions which have been employed are used as terms of description and not of limitation, and there is no intention that in the use of such terms and expressions of excluding any equivalents of the features shown and described or portions thereof, but it is recognised that various modifications are possible within the scope of the invention claimed. Thus, it should be understood that although the present invention has been specifically disclosed by examples, preferred embodiments and optional features, modification and variation of the concepts herein disclosed may be resorted to by those skilled in the art, and that such modificationsand variations are considered to be within the scope of this invention as defined by the appended claims.
[0081] Each reference cited herein is incorporated by reference herein in their entirety. Such references may provide sources of materials; alternative materials, details of methods, as well as additional uses of the invention.
Claims
CLAIMS1. A medication ultrasonication unit, comprising: a processor; a memory coupled with and readable by the processor to cause the processor to perform a plurality of functions controlling the sonication of medication in the medication ultrasonication unit; at least one data receiver in communication with the processor; and an ultrasound transducer generating ultrasonic energy under direction of the processor; wherein the medication ultrasonication unit is adapted to: hold a receptacle loaded with a liquid and a medication dose, receive data relating to the medication dose via the data receiver and transmit the data to the memory, ultrasonicate the dose under control of the plurality of functions, wherein the plurality of functions includes one or more functions for ultrasonicating the medication dose based on the information associated with the data.
2. The ultrasonic unit, according to claim 1, wherein the processor is configured to perform the steps of: receiving data from the data receiver; transmitting the data to the memory, directing the ultrasound transducer to generate ultrasonic energy based on information associated with the data, to liquefy the medication dose in the receptacle.
3. A medication ultrasonication unit according to claim 1 wherein the information associated with the data includes machine instructions developed from an artificial intelligence tool that uses machine learning based on data from interaction with users to determine conditions for liquefaction of medications from a database.RECTIFIED SHEET (RULE 91)4. The ultrasonic unit, according to claim 1, wherein the data receiver comprises one or more wireless transceivers associated with an input / output device chosen from a scanner, a wireless transceiver, a keyboard, a touch screen and / or tactile buttons.
5. The ultrasonic unit, according to claim 1, wherein the data includes information for operation of the ultrasonic unit chosen from a sonication time, control parameters for controlling a frequency of the ultrasonication and the time period for which the frequency is applied.
6. A method of liquefying a solid medication dose using the ultrasonic unit of claim 1, the method comprising the steps of: loading the receptacle with a liquid and a dose of medication, receiving data relating to the medication dose from at least one data receiver, transmitting the data to the memory, and ultrasonicating the dose based on the information associated with the data.
7. A method of producing a liquefied medication dose from a solid medication dose using the ultrasonic unit of claim 1, the method comprising the steps of: locating within the unit, a removable receptacle loaded with a liquid and a dose of medication, receiving data from two or more input / output devices, transmitting the data to the memory, ultrasonicating the dose based on information associated with the data, and removing the receptacle from the unit.
8. A medication dosage liquefied according to the method of claim 6 or claim 7.
9. An ultrasonic unit, according to claim 1, the processor being configured to perform the steps of:RECTIFIED SHEET (RULE 91)receiving data from the data receiver; transmitting the data to the memory, directing the ultrasound transducer to generate ultrasonic energy based on information associated with the data, to liquefy the medication dose in the receptacle.
10. An ultrasonic unit according to claim 9, wherein the processor functions include issuing a warning in response to identification of incompatibility between data cross- referenced from two or more data sources.
11. An ultrasonic unit according to claim 10, wherein the cross-referenced data is chosen from two sources comprising a user prescribed dosage, user identity, medication dosage, or medication packaging.RECTIFIED SHEET (RULE 91)
Citation Information
Patent Citations
Intelligent dosing system with shaking mechanism
CN113116721A
Sonication of a medium
GB2425974A
Device and method for drug action management
KR1020180109327A
Apparatus and method for automatically tuning a fluid temperature PID controller with constraints on the physical characteristics of the process
KR1020210093588A
Ultrasonic dispersion apparatus, system, and method
US20040191275A1
